Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ipsen S.A. | 1 | 0 | 0 | 0 | €109.80 | €109.00 | -0.729% |
| GSK plc ADR | 5 | 0 | 0 | 0 | €38.40 | €49.33 | 28.456% |
| Laboratory Corp. Of America (labcorp) | 13 | 0 | 0 | 0 | €197.00 | €238.58 | 21.106% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €10.21 | - | - |
| Becton, Dickinson & Co. | 10 | 0 | 0 | 0 | €210.30 | €257.91 | 22.638% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €198.00 | - | - |
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €34.19 | - | - |
| Steris Corp. | 1 | 0 | 0 | 0 | €218.00 | - | - |
| Koninklijke Philips Electronics ADR | 3 | 1 | 0 | 0 | €27.40 | - | - |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €143.15 | €165.00 | 15.264% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €13.82 | - | - |
| Smith & Nephew plc ADR | 3 | 0 | 0 | 0 | €27.60 | - | - |
| Teleflex Inc. | 11 | 0 | 0 | 0 | €216.00 | €245.97 | 13.873% |
| Elanco Animal Health Inc. | 8 | 2 | 0 | 0 | €13.06 | €16.17 | 23.810% |
| Merck KGaA | 4 | 1 | 0 | 0 | €169.00 | €172.00 | 1.775% |
| Henry Schein Inc. | 15 | 1 | 0 | 0 | €65.26 | €76.08 | 16.579% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €104.00 | €112.40 | 8.074% |
| Amgen Inc. | 27 | 0 | 0 | 0 | €302.15 | €304.82 | 0.883% |
| Baxter International | 3 | 0 | 0 | 0 | €35.36 | €46.00 | 30.095% |
| Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €139.80 | €145.02 | 3.732% |
| Resmed Inc. | 18 | 1 | 0 | 1 | €215.30 | €215.00 | -0.139% |
| Idexx Laboratories Inc. | 12 | 0 | 0 | 0 | €465.80 | €554.23 | 18.984% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €103.96 | €109.00 | 4.848% |
| Dentsply Sirona Inc. | 17 | 0 | 1 | 0 | €24.13 | €35.04 | 45.213% |
| Roche Holding AG ADR | 4 | 3 | 1 | 1 | €35.40 | €38.00 | 7.357% |